{
    "records": [
        {
            "attributes": {
                "type": "InquiryQuestion",
                "referenceId": "InquiryQuestionRef1"
            },
            "CaseId": "@CaseRef1",
            "Question": "What are the potential drug interactions between our product and commonly prescribed diabetes medications such as metformin and insulin?",
            "ResponseStatus": "NotResponded",
            "Comment": "Specific focus on cardiovascular safety profile and glycemic control implications",
            "SourceSystemName": "Medical Information Portal",
            "SourceSystemIdentifier": "MIP-Q-001"
        },
        {
            "attributes": {
                "type": "InquiryQuestion",
                "referenceId": "InquiryQuestionRef2"
            },
            "CaseId": "@CaseRef1",
            "Question": "Are there specific dosage adjustments recommended for elderly patients with renal impairment?",
            "ResponseStatus": "NotResponded",
            "Comment": "Patient population: 65+ years with moderate chronic kidney disease",
            "SourceSystemName": "Medical Information Portal",
            "SourceSystemIdentifier": "MIP-Q-002"
        },
        {
            "attributes": {
                "type": "InquiryQuestion",
                "referenceId": "InquiryQuestionRef3"
            },
            "CaseId": "@CaseRef2",
            "Question": "How should the reported gastrointestinal symptoms be classified in terms of severity and relationship to the study drug?",
            "ResponseStatus": "Responded",
            "Comment": "Symptoms included nausea and mild abdominal discomfort, resolved within 48 hours",
            "SourceSystemName": "Safety Database",
            "SourceSystemIdentifier": "SDB-Q-045"
        },
        {
            "attributes": {
                "type": "InquiryQuestion",
                "referenceId": "InquiryQuestionRef4"
            },
            "CaseId": "@CaseRef3",
            "Question": "Can you provide the latest Phase III clinical trial results including primary and secondary endpoints?",
            "ResponseStatus": "Responded",
            "Comment": "Data needed for hospital formulary committee evaluation scheduled for next month",
            "SourceSystemName": "Customer Portal",
            "SourceSystemIdentifier": "CP-Q-012"
        },
        {
            "attributes": {
                "type": "InquiryQuestion",
                "referenceId": "InquiryQuestionRef5"
            },
            "CaseId": "@CaseRef3",
            "Question": "What are the absolute and relative contraindications for this medication in cardiac patients?",
            "ResponseStatus": "Responded",
            "Comment": "Specifically interested in patients with history of myocardial infarction or heart failure",
            "SourceSystemName": "Customer Portal",
            "SourceSystemIdentifier": "CP-Q-013"
        }
    ]
} 